Cargando…
Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
INTRODUCTION: Cefoxitin has a good in vitro activity and stability in resistance to hydrolysis by extended-spectrum beta-lactamases and is a good candidate for the treatment of urinary tract infection. However, data are scarce regarding its use in clinical practice. METHODS: We conducted a retrospec...
Autores principales: | Senard, Olivia, Bouchand, Frédérique, Deconinck, Laurene, Matt, Morgan, Fellous, Lesly, Rottman, Martin, Perronne, Christian, Dinh, Aurélien, Davido, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416675/ https://www.ncbi.nlm.nih.gov/pubmed/30891241 http://dx.doi.org/10.1177/2049936118811053 |
Ejemplares similares
-
2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates
por: Senard, Olivia, et al.
Publicado: (2018) -
Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)
por: Deconinck, Laurene, et al.
Publicado: (2019) -
Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
por: Davido, Benjamin, et al.
Publicado: (2018) -
Impact of Fecal Microbiota Transplantation on Digestive Tract Colonization due to Carbapenem-resistant Enterobacteriacae and Vancomycin-resistant Enterococci
por: Davido, Benjamin, et al.
Publicado: (2017) -
Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study
por: Chabert, Paul, et al.
Publicado: (2022)